BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33009502)

  • 21. The Structural Determinants of Intra-Protein Compensatory Substitutions.
    Chaurasia S; Dutheil JY
    Mol Biol Evol; 2022 Apr; 39(4):. PubMed ID: 35349721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer gene discovery using the Sleeping Beauty transposon.
    Starr TK; Largaespada DA
    Cell Cycle; 2005 Dec; 4(12):1744-8. PubMed ID: 16294016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational patterns in oncogenes and tumour suppressors.
    Baeissa HM; Benstead-Hume G; Richardson CJ; Pearl FM
    Biochem Soc Trans; 2016 Jun; 44(3):925-31. PubMed ID: 27284061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary dynamics of oncogenes and tumor suppressor genes: higher intensities of purifying selection than other genes.
    Thomas MA; Weston B; Joseph M; Wu W; Nekrutenko A; Tonellato PJ
    Mol Biol Evol; 2003 Jun; 20(6):964-8. PubMed ID: 12716985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The coupon collector and the suppressor mutation: estimating the number of compensatory mutations by maximum likelihood.
    Poon A; Davis BH; Chao L
    Genetics; 2005 Jul; 170(3):1323-32. PubMed ID: 15879511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenes and tumor suppressor genes.
    Carbone DP
    Hosp Pract (Off Ed); 1993 Jun; 28(6):145-8, 153-6, 161. PubMed ID: 8509476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.
    Glazko GV; Koonin EV; Rogozin IB
    Biochim Biophys Acta; 2004 Aug; 1679(2):95-106. PubMed ID: 15297143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.
    Trigos AS; Pearson RB; Papenfuss AT; Goode DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6406-6411. PubMed ID: 28484005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.
    Wodarz D; Newell AC; Komarova NL
    J R Soc Interface; 2018 Jun; 15(143):. PubMed ID: 29875280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic selection for and against cancer.
    Michor F; Frank SA; May RM; Iwasa Y; Nowak MA
    J Theor Biol; 2003 Dec; 225(3):377-82. PubMed ID: 14604590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing of oncogenes and tumor suppressor genes in odontogenic myxomas.
    Santos JN; Sousa Neto ES; França JA; Diniz MG; Moreira RG; Castro WH; Gomez RS; de Sousa SF; Gomes CC
    J Oral Pathol Med; 2017 Nov; 46(10):1036-1039. PubMed ID: 28597929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inferring the temporal order of cancer gene mutations in individual tumor samples.
    Guo J; Guo H; Wang Z
    PLoS One; 2014; 9(2):e89244. PubMed ID: 24586626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1998 Runme Shaw Memorial Lecture: somatic evolution of cancer.
    Bodmer WF
    Ann Acad Med Singap; 1999 May; 28(3):323-9. PubMed ID: 10575514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene polymorphisms].
    Robert J
    Bull Cancer; 2010 Nov; 97(11):1253-64. PubMed ID: 21115419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa.
    Domazet-Loso T; Tautz D
    BMC Biol; 2010 May; 8():66. PubMed ID: 20492640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and multiple origins of metastatic lineages within primary tumors.
    Zhao ZM; Zhao B; Bai Y; Iamarino A; Gaffney SG; Schlessinger J; Lifton RP; Rimm DL; Townsend JP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2140-5. PubMed ID: 26858460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenes expand during evolution to withstand somatic amplification.
    Wang X; Li X; Zhang L; Wong SH; Wang MHT; Tse G; Dai RZW; Nakatsu G; Coker OO; Chen Z; Ko H; Chan JYK; Liu T; Cheng CHK; Cheng ASL; To KF; Plewczynski D; Sung JJY; Yu J; Gin T; Chan MTV; Wu WKK
    Ann Oncol; 2018 Nov; 29(11):2254-2260. PubMed ID: 30204835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
    Pavel AB; Vasile CI
    J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
    Fleck JL; Pavel AB; Cassandras CG
    BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.